Inside a latest study, we noted the identification and the characterization of a fresh atypical opioid receptor with special adverse regulatory properties to opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a broad-spectrum scavenger for o